Filing Details
- Accession Number:
- 0001093557-21-000169
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-15 18:14:54
- Reporting Period:
- 2021-06-11
- Accepted Time:
- 2021-06-15 18:14:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1850687 | Sumi Shrishrimal | 6340 Sequence Drive San Diego CA 92121 | Svp Chief Risk Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-06-11 | 400 | $401.09 | 12,986 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On November 25, 2020, Ms. Shrishrimal adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Shrishrimal. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- Included in this number are 7,553 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 1,608 of which were granted on March 8, 2019 and shall vest through March 8, 2022.